Market research
ILM1.F Medios AG
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 269M
- P/E ratio
- 23.47
- Analyst target
- 20.25
- Dividend yield
- Not available
- Beta
- 1.26
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Distribution
- ISIN
- DE000A1MMCC8
- Market cap
- 269M
- P/E ratio
- 23.47
- Analyst target
- 20.25
- Dividend yield
- Not available
- Beta
- 1.26
About
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.
Research context
Medios AG appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ILM1.F discussion.
5 years, 7 months ago
Medios AG is currently in a long term downtrend where the price is trading 0.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Medios AG's total revenue rose by 19.6% to $174M since the same quarter in the previous year.
Its net income has dropped by 0.4% to $2M since the same quarter in the previous year.
Finally, its free cash flow fell by 926.5% to $-46M since the same quarter in the previous year.
Based on the above factors, Medios AG gets an overall score of 2/5.